MedTrace Logo

A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children

NCT05577065 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-04-09

No results posted yet for this study

Summary

This study evaluates the efficacy of a single strain probiotic on the incidence, duration and severity of upper respiratory tract infections in healthy, school-age children.

Conditions

  • Upper Respiratory Tract Infections
  • Upper Resp Tract Infection

Interventions

DIETARY_SUPPLEMENT

Probiotic

Single strain probiotic in the form of a sachet with a daily dose of 3E+9 Colony Forming Unit (CFU) per day for 26 weeks.

DIETARY_SUPPLEMENT

Placebo

Matching placebo in the form of a sachet once daily for 26 weeks

Sponsors & Collaborators

  • Atlantia Food Clinical Trials

    collaborator INDUSTRY

  • The Archer-Daniels-Midland Company

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2024-03-13
Completion
2024-03-13

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05577065 on ClinicalTrials.gov